SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 529 filers reported holding SEAGEN INC in Q4 2022. The put-call ratio across all filers is 0.26 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $13,065 | +10.8% | 61,583 | +0.5% | 0.07% | +14.5% |
Q2 2023 | $11,793 | -2.0% | 61,273 | +3.1% | 0.06% | -8.8% |
Q1 2023 | $12,035 | +58.7% | 59,443 | +0.7% | 0.07% | +47.8% |
Q4 2022 | $7,585 | -99.9% | 59,023 | +1.3% | 0.05% | -13.2% |
Q3 2022 | $7,973,000 | -42.8% | 58,273 | -26.1% | 0.05% | -39.8% |
Q2 2022 | $13,946,000 | +42.5% | 78,820 | +16.0% | 0.09% | +63.0% |
Q1 2022 | $9,789,000 | -12.4% | 67,956 | -5.9% | 0.05% | -8.5% |
Q4 2021 | $11,169,000 | -5.6% | 72,246 | +3.6% | 0.06% | -14.5% |
Q3 2021 | $11,837,000 | +14.5% | 69,709 | +6.5% | 0.07% | +15.0% |
Q2 2021 | $10,336,000 | +21.7% | 65,470 | +7.0% | 0.06% | +13.2% |
Q1 2021 | $8,493,000 | -17.0% | 61,160 | +4.7% | 0.05% | -22.1% |
Q4 2020 | $10,232,000 | – | 58,420 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 47,288,259 | $7,465,870,000 | 32.79% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 145,000 | $22,868,000 | 6.04% |
Lagoda Investment Management, L.P. | 59,780 | $9,438,000 | 4.40% |
Avidity Partners Management LP | 640,000 | $101,043,000 | 2.73% |
PFM Health Sciences, LP | 482,985 | $76,254,000 | 2.39% |
Boxer Capital, LLC | 400,000 | $63,152,000 | 2.23% |
Redmile Group, LLC | 771,385 | $121,786,000 | 1.80% |
Woodline Partners LP | 577,655 | $91,200,000 | 1.70% |
Rhenman & Partners Asset Management AB | 157,925 | $24,933,000 | 1.69% |
Parkman Healthcare Partners LLC | 45,176 | $7,132,000 | 1.56% |